TY - JOUR
T1 - Saliva-catalyzed hydrolysis of a ketobemidone ester prodrug
T2 - Factors influencing human salivary esterase activity
AU - Hansen, L.B.
AU - Christrup, Lona Louring
AU - Bundgaard, H.
PY - 1992/1/1
Y1 - 1992/1/1
N2 - Saliva enzyme-catalysed hydrolysis of ester prodrugs or drugs containing sensitive ester groups may be a limiting factor for the buccal absorption of such compounds. Using the isopropyl carbonate ester of ketobemidone as a model substance of a hydrolysis-sensitive prodrug the esterase activity of human saliva has been characterized as a function of various factors. The esterase activity was found to decrease rapidly upon storage of the saliva at 37°C. The activity increased with increasing pH in the range 4.5-7.4 and with increasing salivation flow rate up to a rate of 0.9 ml min. Under resting conditions, the flow rate was about 0.2 ml min which implied a greatly decreased esterase activity. The activity was highest after fasting and decreased after intake of a meal. The intraindividual variation in the saliva esterase activity was small whereas a larger interindividual variation was found.
AB - Saliva enzyme-catalysed hydrolysis of ester prodrugs or drugs containing sensitive ester groups may be a limiting factor for the buccal absorption of such compounds. Using the isopropyl carbonate ester of ketobemidone as a model substance of a hydrolysis-sensitive prodrug the esterase activity of human saliva has been characterized as a function of various factors. The esterase activity was found to decrease rapidly upon storage of the saliva at 37°C. The activity increased with increasing pH in the range 4.5-7.4 and with increasing salivation flow rate up to a rate of 0.9 ml min. Under resting conditions, the flow rate was about 0.2 ml min which implied a greatly decreased esterase activity. The activity was highest after fasting and decreased after intake of a meal. The intraindividual variation in the saliva esterase activity was small whereas a larger interindividual variation was found.
UR - http://www.scopus.com/inward/record.url?scp=0026727250&partnerID=8YFLogxK
U2 - 10.1016/0378-5173(92)90319-W
DO - 10.1016/0378-5173(92)90319-W
M3 - Journal article
AN - SCOPUS:0026727250
SN - 0378-5173
VL - 88
SP - 221
EP - 227
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
IS - 1-3
ER -